Bond GL - Search Results

1

An information-theoretic analysis of genetics, gender and age in cancer patients.

Atwal GS, Rabadán R, Lozano G, Strong LC, Ruijs MW, Schmidt MK, van't Veer LJ, Nevanlinna H, Tommiska J, Aittomäki K, Bougeard G, Frebourg T, Levine AJ, Bond GL. Atwal GS, et al. Among authors: bond gl. PLoS One. 2008 Apr 9;3(4):e1951. doi: 10.1371/journal.pone.0001951. PLoS One. 2008. PMID: 18398474 Free PMC article.

2

A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans.

Bond GL, Levine AJ. Bond GL, et al. Oncogene. 2007 Feb 26;26(9):1317-23. doi: 10.1038/sj.onc.1210199. Oncogene. 2007. PMID: 17322917 Review.

3

MDM2 is a central node in the p53 pathway: 12 years and counting.

Bond GL, Hu W, Levine AJ. Bond GL, et al. Curr Cancer Drug Targets. 2005 Feb;5(1):3-8. doi: 10.2174/1568009053332627. Curr Cancer Drug Targets. 2005. PMID: 15720184 Review.

4

The genetics of the p53 pathway, apoptosis and cancer therapy.

Vazquez A, Bond EE, Levine AJ, Bond GL. Vazquez A, et al. Among authors: bond ee, bond gl. Nat Rev Drug Discov. 2008 Dec;7(12):979-87. doi: 10.1038/nrd2656. Nat Rev Drug Discov. 2008. PMID: 19043449 Review.

5

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ. Bond GL, et al. Among authors: bond ee. Cell. 2004 Nov 24;119(5):591-602. doi: 10.1016/j.cell.2004.11.022. Cell. 2004. PMID: 15550242 Free article.

6

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect.

Bond GL, Hu W, Levine A. Bond GL, et al. Cancer Res. 2005 Jul 1;65(13):5481-4. doi: 10.1158/0008-5472.CAN-05-0825. Cancer Res. 2005. PMID: 15994915 Review.

7

Haplotype structure and selection of the MDM2 oncogene in humans.

Atwal GS, Bond GL, Metsuyanim S, Papa M, Friedman E, Distelman-Menachem T, Ben Asher E, Lancet D, Ross DA, Sninsky J, White TJ, Levine AJ, Yarden R. Atwal GS, et al. Among authors: bond gl. Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4524-9. doi: 10.1073/pnas.0610998104. Epub 2007 Mar 5. Proc Natl Acad Sci U S A. 2007. PMID: 17360557 Free PMC article.

8

MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner.

Bond GL, Hirshfield KM, Kirchhoff T, Alexe G, Bond EE, Robins H, Bartel F, Taubert H, Wuerl P, Hait W, Toppmeyer D, Offit K, Levine AJ. Bond GL, et al. Among authors: bond ee. Cancer Res. 2006 May 15;66(10):5104-10. doi: 10.1158/0008-5472.CAN-06-0180. Cancer Res. 2006. PMID: 16707433 Free article.

9

Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene.

Atwal GS, Kirchhoff T, Bond EE, Montagna M, Menin C, Bertorelle R, Scaini MC, Bartel F, Böhnke A, Pempe C, Gradhand E, Hauptmann S, Offit K, Levine AJ, Bond GL. Atwal GS, et al. Among authors: bond ee, bond gl. Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10236-41. doi: 10.1073/pnas.0901298106. Epub 2009 Jun 4. Proc Natl Acad Sci U S A. 2009. PMID: 19497887 Free PMC article.

10

Recent natural selection identifies a genetic variant in a regulatory subunit of protein phosphatase 2A that associates with altered cancer risk and survival.

Grochola LF, Vazquez A, Bond EE, Würl P, Taubert H, Müller TH, Levine AJ, Bond GL. Grochola LF, et al. Among authors: bond ee, bond gl. Clin Cancer Res. 2009 Oct 1;15(19):6301-8. doi: 10.1158/1078-0432.CCR-09-0797. Epub 2009 Sep 22. Clin Cancer Res. 2009. PMID: 19773383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page